NDC 10370-368 – Topiramate
Topiramate 200 mg/1 · Capsule, Extended Release · Oral
Product NDC10370-368
Product details
- Brand name
- Topiramate
- Generic name
- Topiramate
- Labeler
- Par Health USA, LLC
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA205976
- Marketed since
- March 24, 2023
- Listing expires
- December 31, 2027
Active ingredients
- Topiramate 200 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 10370-368-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-01) | Mar 24, 2023 |
| 10370-368-11 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-11) | Mar 24, 2023 |
Other Topiramate products
- 27241-298 Topiramate 100 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-300 Topiramate 200 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-299 Topiramate 150 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-227 Topiramate 25 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-229 Topiramate 100 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-296 Topiramate 25 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-230 Topiramate 200 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-228 Topiramate 50 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-297 Topiramate 50 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 42291-957 Topiramate 100 mg/1 · Capsule, Extended Release · AvKARE
- 42291-955 Topiramate 25 mg/1 · Capsule, Extended Release · AvKARE
- 42291-956 Topiramate 50 mg/1 · Capsule, Extended Release · AvKARE